Results 11 to 20 of about 1,749 (172)

Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause [PDF]

open access: yesNutrients, 2020
The effects of oral vitamin D supplements on vaginal health in postmenopausal women with vulvovaginal atrophy (VVA) was evaluated. A double-blinded, randomized placebo-controlled trial was conducted for 12 weeks to investigate changes on vaginal maturation index (VMI), vaginal pH, and the visual analog scale (VAS) of VVA symptoms.
Thawinee Kamronrithisorn   +4 more
openaire   +4 more sources

Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study [PDF]

open access: goldSex Med, 2019
Santiago Palacios   +27 more
openalex   +2 more sources

Assessment of the Efficacy and Safety of a Dual-Wavelength Diode Laser System for the Treatment of Vulvovaginal Atrophy in Women Without a History of Breast Cancer and in Patients with a History of Breast Cancer [PDF]

open access: goldJ Clin Med
Gaetano Perrini   +9 more
openalex   +2 more sources

Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up [PDF]

open access: bronzeBreast Cancer Res Treat, 2021
Lucie Véron   +7 more
openalex   +2 more sources

Randomized, Double‐Blind, Placebo‐Controlled Study of Modified Erzhi Granules in the Treatment of Menopause‐Related Vulvovaginal Atrophy [PDF]

open access: goldEvid Based Complement Alternat Med, 2018
Ranran Chen   +5 more
openalex   +2 more sources

Automated brainstem parcellation using multi-atlas segmentation and deep neural network [PDF]

open access: yes, 2021
About 5-8% of individuals over the age of 60 have dementia. With our ever-aging population this number is likely to increase, making dementia one of the most important threats to public health in the 21st century. Given the phenotypic overlap of individual dementias the diagnosis of dementia is a major clinical challenge, even with current gold ...
arxiv   +1 more source

Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial [PDF]

open access: hybridMenopause, 2020
Angelica Lindén Hirschberg   +7 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy